Garza-Rodríguez ML, Pérez-Maya AA, Monsivais-Ovalle DE, Velázquez-Vadillo JF, Barrera-Saldaña HA

Language: Spanish
References: 24
Page: 483-489
PDF size: 359.83 Kb.

ABSTRACT

A biobank facility is one of the most valuable means that academic medical organizations have to offer researchers for improving the competitiveness of their medical research. We describe the implementation of our institutional biobank. Our efforts focused on the design and equipment of work areas, staff training, quality control, bioethical and regulatory issues, generating research collaborations and developing funding strategies. We implemented an institutional biobank at the School of Medicine of the Autonomous University of Nuevo León, Mexico. The biobank has supported more than a dozen research protocols with over 3 000 individuals enrolled and almost 6 000 sampled biospecimens stored. The institutional biobank has become an essential bridge and effective catalyst for research synergies between basic and clinical sciences and it is on its way to becoming a National Laboratory.

REFERENCES

1. Kauffmann F, Cambon-Thomsen A. Tracing biological collections: between books and clinical trials. Jama 2008;299:2316-2318. http://doi.org/fks8b5

2. Somiari SB, Somiari RI. The future of biobanking: A conceptual look at how biobanks can respond to the growing human biospecimen needs of researchers. Adv Exp Med Biol 2015;864:11-27. http://doi.org/bfn6

3. Bevilacqua G, Bosman F, Dassesse T, Hofler H, Janin A, Langer R. The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Archiv: an International Journal of Pathology 2010;456:449- 454. http://doi.org/fgtx9t

4. Vora T, Thacker N. Impacts of a biobank: Bridging the gap in translational cancer medicine. Indian J Med Paediatr Oncol 2015;36:17-23. http://doi. org/bfn7

5. Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 2015;12:e1001779. http://doi.org/bfn8

6. Simon CM, L’Heureux J, Murray JC, et al. Active choice but not too active: Public perspectives on biobank consent models. Genetics in Medicine 2011;13:821-831. http://doi.org/dx2kpd

7. Chadwick D, Roehrl MHA. High-quality biobanking for personalized precision medicine: BioSpecimen Sciences at the helm. Diagnostic Histopathology 2013;19:447–456. http://doi.org/bfn9

8. Garza-Rodríguez ML, Ascacio-Martínez JAI, Pérez-Maya AA, Pérez-Ibave DC, Monsiváis-Ovalle DE, Barrera-Saldaña HB. Biobanks: Experience of the School of Medicine and the “Dr. José Eleuterio González” University Hospital of the Universidad Autónoma de Nuevo León. Medicina Universitaria 2014;16:99-101.

9. Tomlinson T, De Vries R, Kim SY. Ethical standards for research biobank donation--reply. JAMA 2015;313:1574. http://doi.org/bfpb

10. Ley Federal de Protección de Datos Personales en Posesión de los Particulares: Congreso General de los Estados Unidos Mexicanos. México: Diario Oficial de la Federación, 05-07-2010.

11. Artene SA, Ciurea ME, Purcaru SO, Tache DE,Tataranu LG, Lupu M. Biobanking in a Constantly Developing Medical World. Scientific World Journal 2013;343275. http://doi.org/bfpc

12. Eriksson S, Helgesson G. Potential harms, anonymization, and the right to withdraw consent to biobank research. Eur J Hum Genet 2005;13:1071-1076. http://doi.org/dbsw2w

13. Hoeyer K, Olofsson BO, Mjorndal T, Lynoe N. The ethics of research using biobanks: reason to question the importance attributed to informed consent. Arch Intern Med 2005;165:97-100. http://doi.org/d8v2hj

14. Tomlinson T, De Vries R, Ryan K, Kim HM, Lehpamer N, Kim SY. Moral concerns and the willingness to donate to a research biobank. Jama 2015;313:417-419. http://doi.org/bfpd

15. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) (vol 50, pg 298, 2010). Methods 2010;52:268. http://doi.org/fvrtr9

16. Hebels DG, Georgiadis P, Keun HC, Athersuch TJ, Vineis Pk, Vermeulen R. Performance in omics analyses of blood samples in long-term storage: opportunities for the exploitation of existing biobanks in environmental health research. Environ Health Perspect 2013;121:480-487. http://doi.org/f23h6b

17. Ohmomo H, Hachiya T, Shiwa Y, Furukawa R, Ono K, Ho S. Reduction of systematic bias in transcriptome data from human peripheral blood mononuclear cells for transportation and biobanking. PloS one 2014;9. http://doi.org/bfpf

18. Mohamadkhani A, Poustchi H. Repository of human blood derivative biospecimens in biobank: technical implications. Middle East J Dig Dis 2015;7:61-68.

19. Henderson GE, Edwards TP, Cadigan RJ, Davis AM, Zimmer C, Colon I. Stewardship practices of U.S. biobanks. Sci Transl Med 2013;5:215. http:// doi.org/bfpg

20. Nussbeck SY, Skrowny D, O’Donoghue S, Schulze TG, Helbing K. How to design biospecimen identifiers and integrate relevant functionalities into your biospecimen management system. Biopreservation and biobanking 2014;12:199-205. http://doi.org/bfph

21. Ley Federal de Protección de Datos Personales en Posesión de los Particulares. Congreso General de los Estados Unidos Mexicanos. México: Diario Oficial de la Federación, 2010.

22. Sambrook J. Molecular cloning a laboratory manual. New York: Cold Spring harbor Laboratory Press, 2001.

23. OECD Guidelines on Human Biobanks and Genetic Research Databases. Organisation for Economic Co-Operation and Development, 2009. [consultado el 8 de junio de 2016]. Available at: http://www.oecd.org/sti/ biotech/44054609.pdf

24. Zisis K, Piper M, Henderson MK. The 2015 ISBER Annual Meeting & Exhibits in Phoenix, Arizona, USA: bridging the canyon-connecting biobank communities through innovations in global health, research and environmental preservation. Biopreservation and biobanking 2015;13:67-68. http://doi.org/bfpj